![]() |
市场调查报告书
商品编码
1858793
输尿管镜检查:全球市场份额和排名、总销售额和需求预测(2025-2031 年)Ureteroscopy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2024 年全球输尿管镜市场规模估计为 9.44 亿美元,预计到 2031 年将达到 12.46 亿美元,在预测期(2025-2031 年)内复合年增长率为 4.1%。
本报告从跨境产业布局、资本配置模式、区域经济相互依存以及供应链重组等方面,对近期输尿管镜检查的关税调整和国际战略应对措施进行了全面评估。
输尿管镜是一种内视镜技术和器械,用于泌尿系统(主要为输尿管和肾盂)的诊断可视化和微创治疗(例如取石、雷射碎石、切片检查和支架置入)。输尿管镜有半硬式和软式两种类型,整合了光学或数位成像、照明、器械工作通道(取石篮、雷射光纤)和弯曲机构。现代输尿管镜注重高解析度成像、精准操控和耐用性,提供可重复使用和一次性两种型号,适用于术中、床边、门诊和远端医疗等多种场景。输尿管镜在推动微创泌尿系统手术、促进患者復原和提高手术效率方面发挥重要作用,使其成为泌尿系统产品系列和资本投资的核心重点。预计到2024年,全球输尿管镜产量将达到约62,870台,平均全球市场价格约为每台15,000美元。
尿道结石发生率上升、人口老化以及代谢性疾病盛行率增加,推动了临床对先进输尿管镜的需求。根据公司年报和市场分析,一次性输尿管镜和高解析度数位成像系统是关键的成长要素,因为它们降低了交叉感染的风险,并减轻了维修和再处理的工作量。对医院数位化、一体化手术室和加速復健外科(ERAS)通讯协定的投资,进一步推动了对功能更强大、更易于使用和更有效率的设备的采购。政府对基层医疗体系发展和远端医疗的支持,正在推动新兴市场的需求,为供应商提供了拓展地域覆盖范围和实现产品差异化的策略机会。
扩张的同时,也伴随着监管和成本压力。主要製造商的年度报告强调了品管系统、合规性和供应链韧性的核心地位。更严格的医疗设备註册、再处理和环境法规增加了重复使用系统的维护和合规成本。市场也面临来自低成本替代品和新兴的非侵入式监测技术的竞争。采购整合和买方议价能力的增强正在挤压利润空间,迫使企业依靠技术差异化和服务能力来保护价格和市场份额。
临床需求日益分散:复杂、高风险病例需要耐用、高端、可重复使用的内视镜,而常规诊疗和基层医疗机构则倾向于一次性、低维护、模组化解决方案。据仲介业者和行业报告显示,医院优先考虑术中工作流程效率、可视化效果以及与雷射和取栓工具的集成,而门诊和基层医疗机构则优先考虑设备准备就绪性和总体拥有成本。患者预后(復健体验和併发症发生率)也越来越影响采购决策。
上游加工投入包括光学模组(微型相机和镜头)、光纤和照明系统、柔性聚合物和关节材料、金属/合金驱动组件以及一次性设备的聚合物机壳/密封件。高品质的成像技术和精密机械组件集中在少数几家专业的微电子和精密製造供应商手中,导致供应链高度集中。根据年度报告和监管文件,设备的可用性和耐用性取决于光学和机械材料以及製造流程。原材料和电子元件供应的波动以及日益严格的环境法规都会影响前置作业时间和成本。因此,製造商正日益倾向于本地化供应商、多元化供应商来源并严格筛选供应商,以降低风险并确保临床应用的连续性。该行业的平均毛利率为 60-75%。
本报告旨在按地区/国家、类型和应用对全球输尿管镜市场进行全面分析,重点关注总销售量、收入、价格、市场份额和主要企业的排名。
输尿管镜市场规模、估计和预测以销售(千台)和收入(百万美元)为单位呈现,基准年为2024年,并包含2020年至2031年的历史数据和预测数据。报告采用定量和定性分析相结合的方法,帮助读者制定业务和成长策略,评估市场竞争,分析自身在当前市场中的地位,并为输尿管镜业务做出明智的决策。
市场区隔
公司
按类型分類的细分市场
应用领域
按地区
The global market for Ureteroscopy was estimated to be worth US$ 944 million in 2024 and is forecast to a readjusted size of US$ 1246 million by 2031 with a CAGR of 4.1% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Ureteroscopy cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Ureteroscopy is an endoscopic technique and device category used for diagnostic visualization and minimally invasive treatment within the urinary tract, primarily the ureter and renal pelvis, including stone retrieval, laser lithotripsy, biopsy, and stent placement. Devices come in semi-rigid and flexible variants and integrate optical or digital imaging, illumination, working channels for instruments (baskets, laser fibers), and deflection mechanisms. Modern ureteroscopes emphasize high-resolution imaging, precise maneuverability, durability, and offer both reusable and single-use models to suit intraoperative, bedside, outpatient, and remote care settings. Their role in advancing minimally invasive urology, accelerating recovery, and improving operative efficiency makes them central to urology product portfolios and capital investment.In 2024, global Ureteroscopy production reached approximately 62.87 k units, with an average global market price of around US$ 15000 perunit.
Rising incidence of urolithiasis, an aging population, and metabolic disorders are fueling clinical demand for advanced ureteroscopes. Company annual reports and market analyses indicate that single-use ureteroscopes and high-resolution digital imaging systems are key growth drivers because they reduce cross-contamination risk and lower repair/reprocessing burdens. Investments in hospital digitalization, integrated ORs, and ERAS protocols further drive procurement of higher-performance, more maneuverable and efficient devices. Government support for primary care capacity building and telemedicine is unlocking demand in emerging markets, offering vendors strategic opportunities to expand geographic reach and differentiate product lines.
Expansion is coupled with regulatory and cost pressures. Leading manufacturers' annual reports emphasize the centrality of quality systems, regulatory compliance, and supply-chain resilience; stricter device registration, reprocessing and environmental rules increase maintenance and compliance costs for reusable systems. The market also faces competition from low-cost alternatives and emerging non-invasive monitoring technologies. Purchasing consolidation and stronger buyer negotiation power compress margins, forcing companies to rely on technological differentiation and service capabilities to defend pricing and share.
Clinical demand is becoming more segmented: complex and high-risk cases call for durable, high-end reusable scopes, while routine care and primary settings favor disposable, low-maintenance or modular solutions. Brokerage and industry reports note heightened hospital focus on intraoperative workflow efficiency, visualization and integration with lasers and retrieval tools; outpatient and primary sites prioritize readiness and total cost of ownership. Patient outcomes-recovery experience and complication rates-are increasingly influential in procurement decisions.
Upstream inputs include optical modules (miniature cameras, lenses), fiber optics and illumination systems, flexible polymers and articulation materials, metal/alloy drive components, and polymer housings/seals for disposable devices. High-quality imaging and precision mechanical parts are concentrated among a few specialized micro-electronics and precision-manufacturing suppliers, leading to supply-chain concentration. Annual reports and regulatory filings indicate device availability and durability hinge on materials and manufacturing processes for optics and mechanics; fluctuations in raw-material or electronic component supply and tightening environmental compliance can affect lead times and costs. Consequently, manufacturers pursue supplier localization, multi-sourcing and rigorous supplier qualification to mitigate risks and ensure clinical continuity. The average gross profit margin in this industry is 60-75%.
This report aims to provide a comprehensive presentation of the global market for Ureteroscopy, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ureteroscopy by region & country, by Type, and by Application.
The Ureteroscopy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ureteroscopy.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Ureteroscopy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Ureteroscopy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Ureteroscopy in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.